RGC NASDAQ
Regencell Bioscience Holdings Limited
1W: +14.3%
1M: -22.2%
3M: -78.8%
YTD: -71.6%
1Y: -61.6%
3Y: +842.7%
$5.97
+0.14 (+2.40%)
Weekly Expected Move ±27.4%
$3
$4
$6
$7
$9
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.0B
52W Range4.51-69
Volume163,000
Avg Volume277,927
Beta1.83
Dividend$0.88
Analyst Ratings
Company Info
CEOYat-Gai Au
Employees10
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-07-16
Websiteregencellbioscience.com
First Commercial Building
Causeway Bay KY1-1107
HK
Causeway Bay KY1-1107
HK
852 2155 0823
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Latest News
Regencell Bioscience (NASDAQ:RGC) Trading 12% Higher - Should You Buy? - MarketBeat
Price to earnings forward of Regencell Bioscience Holdings Limited – NASDAQ:RGC - TradingView
Regencell Bioscience stock hits 52-week low at 4.91 USD - Investing.com
Regencell Bioscience (RGC) Sees 25.2% Surge in Stock Price - GuruFocus
United Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises (NASDAQ:RGC) - Seeking Alpha
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| LO MARGARET HOOR HAN | 0 | — | 2026-03-18 | |
| AU YAT-PUI | 0 | — | 2026-03-18 | |
| AU YAT-GAI | 0 | — | 2026-03-18 | |
| LO WILLIAM WING YAN | 592,230 | $0.84 | 2026-03-18 | |
| TYRRELL JACK | D-Return | 136,684 | $23.00 | 2018-02-28 |